Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis (Q40810407)
Jump to navigation
Jump to search
scientific article published on 5 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis |
scientific article published on 5 February 2013 |
Statements
1 reference
Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis (English)
1 reference
Yanan Guo
1 reference
David J Kwiatkowski
1 reference
5 February 2013
1 reference
1 reference
11
1 reference
5
1 reference
467-473
1 reference
Identifiers
1 reference
1 reference
1 reference